Bill Summary
The resolution aims to raise awareness and support for chordoma, a rare and aggressive type of bone cancer that primarily affects the skull and spine. It highlights the disease's prevalence, impacting over 25,000 individuals globally and around 300 annually in the U.S. Chordomas are particularly challenging to treat due to their location near critical brain and spinal structures, which complicates surgical interventions and increases the likelihood of recurrence. Currently, there are no effective drugs to cure or manage the disease once it progresses. The resolution calls for increased funding and support to improve early diagnosis, develop new treatments, streamline research processes, and adopt patient-centric approaches in drug development for chordoma patients and their families.
Possible Impacts
Here are three examples of how the resolution regarding raising awareness for chordoma cancer could affect people:
1. **Increased Access to Research Funding**: The resolution calls for increased funding and support for research into chordoma, which could lead to the development of new treatments and diagnostics. This would directly benefit patients by providing more options for treatment, potentially improving their prognosis and quality of life.
2. **Greater Awareness and Education**: By raising awareness about chordoma, healthcare professionals and the general public may become more informed about the disease. This could lead to earlier diagnosis and intervention for patients, which is crucial given the aggressive nature of chordoma. Increased awareness may also encourage individuals to seek medical advice sooner when experiencing relevant symptoms.
3. **Advocacy for Patient-Centric Approaches**: The resolution emphasizes the need for patient-centric approaches in drug discovery and development. This could result in treatments that are more tailored to the specific needs and experiences of chordoma patients. For instance, it may lead to the involvement of patients in clinical trials or research to ensure that new therapies are effective and address the unique challenges faced by those with chordoma.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 172 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. RES. 172
Raising awareness for the sarcoma cancer chordoma.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 27, 2025
Mr. Johnson of Georgia (for himself, Mrs. McBath, Ms. Wilson of
Florida, Ms. Velazquez, and Ms. Norton) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Raising awareness for the sarcoma cancer chordoma.
Whereas chordoma is a slow growing, yet aggressive bone cancer of the skull and
spine;
Whereas it strikes people of all ages and affects more than 25,000 individuals
worldwide;
Whereas, each year, thousands of people are diagnosed with chordoma including
about 300 people annually in the United States;
Whereas chordomas are among the most complicated tumors to treat due to
involvement of critical structures such as the brain stem, spinal cord,
and important nerves and arteries;
Whereas surgery or radiation performed by a skilled treatment team can be
curative for some patients, but even with the best care possible, the
recurrence rate remains high; and
Whereas no drugs are known to cure or effectively control the disease, meaning
that patients whose disease progresses after exhausting surgical and
radiation options have little hope for a full recovery: Now, therefore,
be it
Resolved, That it is the sense of the House of Representatives that
chordoma patients and families need increased funding and support for--
(1) accurate and early diagnosis;
(2) the development of new treatments, diagnostics, and
cures;
(3) fewer hurdles between research and new treatments; and
(4) patient-centric approaches to drug discovery and
development.
<all>